Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus O Butler

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Nature Communications|May 17, 2018
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy modelsYuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse EventsDaniel V Araujo, Thiago Pimentel Muniz, Anjie Yang, et al.
Nature Medicine|February 6, 2018
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effectsYuki Kagoya, Shinya Tanaka, Tingxi Guo, et al.
The Journal of Clinical Investigation|August 23, 2016
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy modelsYuki Kagoya, Munehide Nakatsugawa, Yuki Yamashita, et al.
Cancer Medicine|September 30, 2016
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanomaLeila Khoja, Eshetu G Atenafu, Arnoud Templeton, et al.
Blood|October 22, 2005
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificityNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric HemichainTingxi Guo, Toshiki Ochi, Munehide Nakatsugawa, et al.
International Immunology|November 10, 2010
A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR allelesMarcus O Butler, Sascha Ansén, Makito Tanaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and OpportunitiesChristina S Baik, Eric H Rubin, Patrick M Forde, et al.
Scientific Reports|March 21, 2018
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP<sup>84Gly</sup>Mark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Nature Communications|May 17, 2018
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy modelsYuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse EventsDaniel V Araujo, Thiago Pimentel Muniz, Anjie Yang, et al.
Nature Medicine|February 6, 2018
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effectsYuki Kagoya, Shinya Tanaka, Tingxi Guo, et al.
The Journal of Clinical Investigation|August 23, 2016
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy modelsYuki Kagoya, Munehide Nakatsugawa, Yuki Yamashita, et al.
Cancer Medicine|September 30, 2016
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanomaLeila Khoja, Eshetu G Atenafu, Arnoud Templeton, et al.
Blood|October 22, 2005
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificityNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric HemichainTingxi Guo, Toshiki Ochi, Munehide Nakatsugawa, et al.
International Immunology|November 10, 2010
A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR allelesMarcus O Butler, Sascha Ansén, Makito Tanaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and OpportunitiesChristina S Baik, Eric H Rubin, Patrick M Forde, et al.
Scientific Reports|March 21, 2018
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP<sup>84Gly</sup>Mark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa, et al.
Pageof 13